Listen to PolTREG S.A. CEO Prof Piotr Trzonkowski explaining how we are using a special type of white blood cell as a therapy to contain a wide range of autoimmune diseases on the Empowered Patient Podcast with U.S. reporter Karen Jagoda. “T-regulatory cells are a kind of military police of the immune system […so that…] the immune system fights with bacteria and virus cells, and does not touch our own tissue,” Prof Trzonkowski said in this 20-minute conversation. To listen to the podcast, or read the transcript, click on this link: https://lnkd.in/d5x6V8dy
Listen to PolTREG CEO Prof Piotr Trzonkowski explaining how we are using a special type of white blood cell as a therapy to contain a wide range of autoimmune diseases on the Empowered Patient Podcast with U.S. reporter Karen Jagoda. “T-regulatory cells are a kind of military police of the immune system […so that…] the immune system fights with bacteria and virus cells, and does not touch our own tissue,” Prof Trzonkowski said in this 20-minute conversation. The company is already well-advanced in testing this “military police of the immune system” in clinical tests in type 1 diabetes and multiple sclerosis. PolTREG is the only company that has more than 10 years’ worth of patient safety and efficacy data with Treg autologous polyclonal therapies, which we obtained from patients in clinical trials and through hospital exemptions in Poland. To listen to the podcast, or read the transcript, click on this link: https://lnkd.in/d5x6V8dy #T1D #biotech #biotechnology #celltherapy #cellandgenetherapy #autoimmunedisease #diabetes #type1diabetes #multiplesclerosis
